10673309

Source:http://linkedlifedata.com/resource/pubmed/id/10673309

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0002199, umls-concept:C0008976, umls-concept:C0022635, umls-concept:C0023981, umls-concept:C0205195, umls-concept:C0205466, umls-concept:C0332161, umls-concept:C0332173, umls-concept:C0524910, umls-concept:C0871261, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2911692
pubmed:issue	3
pubmed:dateCreated	2000-3-23
pubmed:abstractText	Less than 15% of patients with chronic hepatitis C show a sustained virological response to interferon treatment.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-10051978, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-10673287, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-1713568, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-1898993, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-2509917, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-3072574, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-4560273, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-6154736, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-6170683, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-6983912, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-7560864, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-7590646, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-7699263, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-7739681, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-8389799, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-8551006, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-8583134, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-8684203, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-8855176, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-9218853, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-9303505, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-9305670, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-9572325, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-9732947, http://linkedlifedata.com/resource/pubmed/commentcorrection/10673309-9819446
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985108R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Ketoprofen, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0017-5749
pubmed:author	pubmed-author:BartelliniM AMA, pubmed-author:CabanneAA, pubmed-author:FlichmanDD, pubmed-author:GonzálezJJ, pubmed-author:GorínJ MJM, pubmed-author:LeviDD, pubmed-author:MuñozA EAE, pubmed-author:MunneM SMS, pubmed-author:PodestáAA, pubmed-author:TeraTT
pubmed:issnType	Print
pubmed:volume	46
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	427-31
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:10673309-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:10673309-Antiviral Agents, pubmed-meshheading:10673309-Drug Administration Schedule, pubmed-meshheading:10673309-Drug Therapy, Combination, pubmed-meshheading:10673309-Female, pubmed-meshheading:10673309-Hepatitis C, Chronic, pubmed-meshheading:10673309-Humans, pubmed-meshheading:10673309-Interferon-alpha, pubmed-meshheading:10673309-Ketoprofen, pubmed-meshheading:10673309-Male, pubmed-meshheading:10673309-Middle Aged, pubmed-meshheading:10673309-Prospective Studies, pubmed-meshheading:10673309-Recombinant Proteins
pubmed:year	2000
pubmed:articleTitle	Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial.
pubmed:affiliation	Unidad de Hepatología, Hospital Dr Bonorino Udaondo, School of Medicine, University of Salvador, Buenos Aires, Argentina.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial